Peyton R Howell

TNDM

Peyton R Howell serves as Director at Tandem Diabetes Care, Inc. (TNDM). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$240.2K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$240.2K

Companies Traded

TNDM

Active Period

May 2022 – May 2023

2 total trades

Most Recent

Buy TNDM

May 19, 2023 · $90.5K

Peyton R Howell's Insider Trading at Tandem Diabetes Care, Inc. (TNDM)

Buys

2 · $240.2K

Sells

0 · $0.00

Total Shares Bought

5,000

Total Shares Sold

TNDM Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 19, 2023	Buy	3,000	$30.16	$90.5K	8,550
May 10, 2022	Buy	2,000	$74.85	$149.7K	2,948

Related Insiders

Mark David Novara

officer: EVP & CHIEF COMMERCIAL OFFICER

TNDMSell · Mar 18, 2026

Elizabeth Anne Gasser

EVP, Chief Strategy Officer

TNDMSell · Feb 17, 2026

Shannon Marie Hansen

EVP & Chief Legal Officer

TNDMSell · Feb 17, 2026

Rick Carpenter

Chief Technology Officer

TNDMSell · Feb 17, 2026

John F Sheridan

PRESIDENT & CEO

TNDMSell · Feb 17, 2026

Leigh Vosseller

EVP & CHIEF FINANCIAL OFFICER

TNDMSell · Feb 17, 2026

Susan Morrison

EVP & Chief Admin. Officer

TNDMSell · Feb 17, 2026

Explore More Insider Trading Data

TNDM Insider Trading Activity

View all insider trades at Tandem Diabetes Care, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity